David B Duggan
Affiliation: SUNY Upstate Medical University
- Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trialDavid B Duggan
Department of Medicine, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
J Clin Oncol 21:607-14. 2003..We compared these regimens as initial chemotherapy for Hodgkin's disease...
- Every error a treasure: improving medication use with a nonpunitive reporting systemDavid F Lehmann
Department of Medicine, State University of New York Upstate Medical Universtiy, Syracuse, New York, USA
Jt Comm J Qual Patient Saf 33:401-7. 2007..The revised medication event reporting policy, as established in October 2000 for all staff, severed the link between reporting errors and performance evaluations...
- Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancerI Craig Henderson
University of California at San Francisco, San, Francisco, CA 94143, USA
J Clin Oncol 21:976-83. 2003..This study was designed to determine whether increasing the dose of doxorubicin in or adding paclitaxel to a standard adjuvant chemotherapy regimen for breast cancer patients would prolong time to recurrence and survival...